Should we incorporate topical epinephrine in the ESGE guideline on prevention of post-ERCP pancreatitis?

Pancreatitis remains the most frequent and lethal adverse event (AE) that may follow endoscopic retrograde cholangiopancreatography (ERCP). Fortunately, it is also the only AE for which significant advances have been made. Since 2010, four scientific societies have issued guidelines about the prophylaxis of post-ERCP pancreatitis (PEP). All of them have recommended rectal nonsteroidal anti-inflammatory drugs (NSAIDs) as the cornerstone of pharmacological prophylaxis of PEP ([Table 1]).

Publication History

Article published online:
21 July 2020

• References

• 1 Dumonceau J-M, Rigaux J, Kahaleh M. et al. Prophylaxis of post-ERCP pancreatitis: a practice survey. Gastrointest Endosc 2010; 71: 934-9-939.e1-2
• 2 Hanna MS, Portal AJ, Dhanda AD. et al. UK wide survey on the prevention of post-ERCP pancreatitis. Frontline Gastroenterol 2014; 5: 103-110
• 3 Lopes L, Canena J. ERCP in Portugal: a wide survey on the prevention of post-ERCP pancreatitis and papillary cannulation techniques. Port J Gastroenterol 2019; 26: 14-23
• 4 Avila P, Holmes I, Kouanda A. et al. Practice patterns of post-ERCP pancreatitis prophylaxis techniques in the United States: a survey of advanced endoscopists. Gastrointest Endosc 2020; 91: 568-573.e2
• 5 Dumonceau J-M, Kapral C, Aabakken L. et al. ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2020; 52: 127-149
• 6 Elmunzer BJ, Hernandez I, Gellad WF. The skyrocketing cost of rectal indomethacin. JAMA Intern Med 2020; 180: 631-632
• 7 Iqbal U, Siddique O, Khara H. et al. Post endoscopic retrograde cholangiopancreatography pancreatitis prevention using topical epinephrine: a systematic review and meta-analysis. Endosc Int Open 2020; 08: E1061-E1067
• 8 Akshintala VS, Hutfless SM, Colantuoni E. et al. Systematic review with network meta-analysis: pharmacological prophylaxis against post-ERCP pancreatitis. Aliment Pharmacol Ther 2013; 38: 1325-1337
• 9 Chandrasekhara V, Khashab MA, Muthusamy VR. et al. Adverse events associated with ERCP. Gastrointest Endosc 2017; 85: 32-47
• 10 Mine T, Morizane T, Kawaguchi Y. et al. Clinical practice guideline for post-ERCP pancreatitis. J Gastroenterol 2017; 52: 1013-1022
• 11 Bai Y, Li DF, Wang SL. et al. Chinese expert consensus on perioperative medications for endoscopic retrograde cholangiopancreatography (ERCP). J Dig Dis 2019; 20: 103-113
• 12 Xu LH, Qian JB, Gu LG. et al. Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis by epinephrine sprayed on the papilla. J Gastroenterol Hepatol 2011; 26: 1139-1144
• 13 Matsushita M, Takakuwa H, Shimeno N. et al. Epinephrine sprayed on the papilla for prevention of post-ERCP pancreatitis. J Gastroenterol 2009; 44: 71-75
• 14 Chaitanya K, Murali Krishna P, Repana K. et al. Efficacy of rectal indomethacin versus papillary epinephrine spray in prevention of post-ERCP pancreatitis. Indian J Gastroenterol 2016; 35: A93
• 15 Ohashi A, Tamada K, Tomiyama T. et al. Epinephrine irrigation for the prevention of pancreatic damage after endoscopic balloon sphincteroplasty. J Gastroenterol Hepatol 2001; 16: 568-571
• 16 Nakaji K, Suzumura S, Nakae Y. et al. Effects in the control of edema of the papilla of Vater by epinephrine saline irrigation after endoscopic retrograde cholangiopancreatography in an endoscopy center in Japan, 2003 to 2007: exploratory retrospective analysis to evaluate the characteristics of eligible patients with a focus on serum amylase levels. Intern Med 2009; 48: 945-952
• 17 Sawas T, Bazerbachi F, Haffar S. et al. End-stage renal disease is associated with increased post endoscopic retrograde cholangiopancreatography adverse events in hospitalized patients. World J Gastroenterol 2018; 24: 4691-4697
• 18 Dumonceau JM, Andriulli A, Devière J. et al. European Society of Gastrointestinal Endoscopy (ESGE) Guideline: prophylaxis of post-ERCP pancreatitis. Endoscopy 2010; 42: 503-515